Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
Investar Holding Corp
ISTR
$415M
| $804K | ﹤0.01% |
34,623
-3,602
| -9% | -$80.8K |
|
3452
Hackett Group
HCKT
$270M
| $804K | ﹤0.01% |
42,270
-15,897
| -27% | -$347K |
|
3453
Financial Institutions
FISI
$816M
| $804K | ﹤0.01% |
29,542
-11,836
| -29% | -$316K |
|
3454
Consensus Cloud Solutions
CCSI
$670M
| $802K | ﹤0.01% |
27,322
-4,983
| -15% | -$124K |
|
3455
International Money Express
IMXI
$357M
| $802K | ﹤0.01% |
57,379
-7,089
| -11% | -$87.8K |
|
3456
PUT
Dyne Therapeutics
DYN
$4.7B
| $801K | ﹤0.01% |
+63,300
| New | +$722K |
|
3457
Eton Pharmaceutcials
ETON
$1.27B
| $800K | ﹤0.01% |
36,806
-8,984
| -20% | -$149K |
|
3458
Tyra Biosciences
TYRA
$1.9B
| $799K | ﹤0.01% |
57,126
-4,429
| -7% | -$50.5K |
|
3459
VanEck Junior Gold Miners ETF
GDXJ
$6.89B
| $797K | ﹤0.01% |
8,053
+1,263
| +19% | +$97.1K |
|
|
AHL
3460
DELISTED
Aspen Insurance
AHL
| $797K | ﹤0.01% |
21,716
+21,315
| +5,315% | +$701K |
|
3461
Sigma Lithium
SGML
$1.11B
| $796K | ﹤0.01% |
124,173
+84,409
| +212% | +$508K |
|
3462
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
| $795K | ﹤0.01% |
11,135
| – | – |
|
3463
Fortis
FTS
$29B
| $794K | ﹤0.01% |
15,647
+1,726
| +12% | +$84.9K |
|
|
RAPP
3464
Rapport Therapeutics
RAPP
$1.96B
| $793K | ﹤0.01% |
26,713
-44,395
| -62% | -$792K |
|
3465
United States Natural Gas Fund
UNG
$456M
| $787K | ﹤0.01% |
60,219
+32,101
| +114% | +$430K |
|
3466
Scholastic
SCHL
$767M
| $785K | ﹤0.01% |
28,663
-16,712
| -37% | -$413K |
|
3467
Southern California Bancorp
BCAL
$684M
| $782K | ﹤0.01% |
46,895
+2,139
| +5% | +$35.1K |
|
|
ATXS
3468
DELISTED
Astria Therapeutics
ATXS
| $780K | ﹤0.01% |
107,109
-10,425
| -9% | -$70.5K |
|
3469
Forward Air
FWRD
$444M
| $780K | ﹤0.01% |
30,406
-13,226
| -30% | -$381K |
|
|
BBBY
3470
Bed Bath & Beyond
BBBY
$481M
| $780K | ﹤0.01% |
87,593
-18,593
| -18% | -$154K |
|
3471
Regional Management Corp
RM
$301M
| $779K | ﹤0.01% |
20,005
-5,891
| -23% | -$222K |
|
3472
Oak Valley Bancorp
OVLY
$285M
| $779K | ﹤0.01% |
27,663
+1,874
| +7% | +$52.5K |
|
3473
Compass Therapeutics
CMPX
$344M
| $778K | ﹤0.01% |
222,418
-19,303
| -8% | -$61K |
|
3474
Direxion Daily Technology Bull 3x ETF
TECL
$5.08B
| $777K | ﹤0.01% |
6,250
+100
| +2% | +$10.5K |
|
|
SERV
3475
Serve Robotics
SERV
$407M
| $774K | ﹤0.01% |
66,587
-35,753
| -35% | -$392K |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.